| A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases Z Li, J Wu, J Zhou, B Yuan, J Chen, W Wu, L Mo, Z Qu, F Zhou, Y Dong, ... MBio 12 (5), 10.1128/mbio. 02542-21, 2021 | 19 | 2021 |
| Therapeutic targeting of vimentin by ALD-R491 impacts multiple pathogenic processes to attenuate acute and chronic colitis in mice J Wu, X Wu, C Cheng, L Liu, L Xu, Z Xu, S Wang, D Symmes, L Mo, ... Biomedicine & Pharmacotherapy 168, 115648, 2023 | 1 | 2023 |
